Breaking News Instant updates and real-time market news.

ADVM

Adverum Biotechnologies

$3.67

-0.14 (-3.67%)

07:01
10/14/16
10/14
07:01
10/14/16
07:01

Adverum Biotechnologies appoints Amber Salzman, Ph.D. as CEO

Adverum Biotechnologies announced that former CEO Paul Cleveland has been appointed Executive Chairman of the board and that Amber Salzman, Ph.D., formerly president and COO, has been appointed CEO.

  • 15

    Oct

ADVM Adverum Biotechnologies
$3.67

-0.14 (-3.67%)

05/27/16
COWN
05/27/16
INITIATION
COWN
Outperform
Adverum Biotechnologies reinstated with an Outperform at Cowen
Cowen reinstated Adverum Biotechnologies with an Outperform rating after the closing of its acquisition of Annapurna. The firm sees several key upcoming events and expects the shares to outperform should any of its programs progress through clinical development.
06/08/16
CHDN
06/08/16
DOWNGRADE
Target $5
CHDN
Neutral
Adverum Biotechnologies downgraded to Neutral from Buy at Chardan

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.